VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer

This study is currently recruiting participants.
Verified February 2014 by Vaximm GmbH
Information provided by (Responsible Party):
Vaximm GmbH
ClinicalTrials.gov Identifier:
First received: December 2, 2011
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
No publications provided by Vaximm GmbH

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):